Invasive potency related to RCAS1 expression in uterine cervical cancer

Gynecologic Oncology

Volumn 99, Issue 1, 2005, Pages 189-198

  Sonoda, Kenzo ^a   Miyamoto, Shingo ^a   Hirakawa, Toshio ^a   Yagi, Hiroshi ^a   Yotsumoto, Fusanori ^a   Nakashima, Manabu ^b   Watanabe, Takeshi ^c   Nakano, Hitoo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Connective tissue remodeling; Immunohistochemistry; Prognostic factors; RCAS1; Uterine cervical cancer

Indexed keywords

INTERSTITIAL COLLAGENASE; KALININ; TUMOR ANTIGEN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STROMA CELL; TUMOR VOLUME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

ADULT; AGED; ANTIGENS, NEOPLASM; CARCINOGENS; CELL LINE, TUMOR; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES; STROMAL CELLS; SURVIVAL RATE; TETRADECANOYLPHORBOL ACETATE; UTERINE CERVICAL NEOPLASMS;

EID: 25144463888     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.06.061     Document Type: Article

References (60)

1. S.A. Cannistra, and J.M. Niloff Cancer of the uterine cervix N. Engl. J. Med. 334 1996 1030 1038
2. National Cancer Institute Statistics of cervix uteri cancer 2003 National Cancer Institute Rockville, MD
3. E. Burghardt, H. Pickel, J. Haas, and M. Lahousen Prognostic factors and operative treatment of stages IB to IIB cervical cancer Am. J. Obstet. Gynecol. 156 1987 988 996
4. H. Noguchi, I. Schiozawa, Y. Sakai, T. Yamazaki, and T. Fukuta Pelvic lymph node metastasis of uterine cervical cancer Gynecol. Oncol. 27 1987 150 185
5. T. Kamura, N. Tsukamoto, N. Tsuruchi, T. Saito, T. Matsuyama, K. Akazawa, and H. Nakano Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy Cancer 69 1992 181 186
6. H. Pickel, J. Haas, and M. Lahousen Prognostic factors in cervical cancer Eur. J. Obstet. Gynecol. Reprod. Biol. 71 1997 209 213
7. F.B. Stehman, C.A. Perez, R.J. Kurman, and J.T. Thigpen Uterine cervix W.J. Hoskins C.A. Perez R.C. Young Principles and practice of gynecologic oncology 3rd ed. 2000 Lippincott Williams and Wilkins Philadelphia 841 918
8. P.L. Moser, D.G. Kieback, L. Hefler, C. Tempfer, W. Neunteufel, and G. Gitsch Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage IB cervical cancer Anticancer Res. 19 1999 4391 4393
9. B. Skyldberg, S. Salo, E. Eriksson, U. Aspenblad, B. Moberger, and K. Tryggvason Laminin-5 as a marker of invasiveness in cervical lesions J. Natl. Cancer Inst. 91 1999 1882 1887
10. T.J. De Vries, P.E. De Wit, I. Clemmensen, H.W. Verspaget, U.H. Weidle, and E.B. Brocker Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions J. Pathol. 179 1996 260 265
11. D. Albo, V.L. Rothman, D.D. Roberts, and G.P. Tuszynski Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor Br. J. Cancer 83 2000 298 306
12. T.N. Wang, X. Qian, M.S. Granick, M.P. Solomon, V.L. Rothman, and D.H. Berger Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer J. Surg. Res. 63 1996 39 43
13. M. Nakashima, K. Sonoda, and T. Watanabe Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 Nat. Med. 5 1999 938 942
14. K. Sonoda, M. Nakashima, T. Kaku, T. Kamura, H. Nakano, and T. Watanabe A novel tumor-associated antigen expression in human uterine and ovarian carcinomas Cancer 77 1996 1501 1509
15. K. Sonoda, T. Kaku, T. Kamura, M. Nakashima, T. Watanabe, and H. Nakano Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias Clin. Cancer Res. 4 1998 1517 1520
16. K. Razvi, K. Sonoda, Y.S. Lee, K.F. Tham, F.K. Lim, and E.L. Yong A preliminary study of the immunohistochemical detection of a novel tumour marker, 22-1-1 antigen, in gynaecological cancer specimens Ann. Acad. Med. Singap. 28 1999 392 394
17. T. Kaku, K. Sonoda, T. Kamura, T. Hirakawa, K. Sakai, and S. Amada The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix Clin. Cancer Res. 5 1999 1449 1453
18. T. Iwasaki, M. Nakashima, T. Watanabe, S. Yamamoto, Y. Inoue, and H. Yamanaka Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1 Int. J. Cancer 89 2000 488 493
19. M. Izumi, Y. Nakanishi, I. Yoshino, M. Nakashima, T. Watanabe, and N. Hara Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell carcinoma Cancer 92 2001 446 451
20. S. Oizumi, K. Yamazaki, M. Nakashima, T. Watanabe, F. Hommura, and S. Ogura RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung Oncology 62 2002 333 339
21. T. Oshikiri, Y. Hida, M. Miyamoto, H. Hashida, K. Katoh, and M. Suzuoki RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer Br. J. Cancer 85 2001 1922 1927
22. M. Suzuoki, Y. Hida, M. Miyamoto, T. Oshiriki, K. Hiraoka, and Y. Nakakubo RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma Ann. Surg. Oncol. 9 2002 388 393
23. K. Hiraoka, Y. Hida, M. Miyamoto, T. Oshikiri, M. Suzuoki, and Y. Nakakubo High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker Int. J. Cancer 99 2002 418 423
24. Y. Nakakubo, Y. Hida, M. Miyamoto, H. Hashida, T. Oshiriki, and K. Kato The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus Cancer Lett. 177 2002 101 105
25. K. Sonoda, T. Kaku, T. Hirakawa, H. Kobayashi, S. Amada, and K. Sakai The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant endometrium Gynecol. Oncol. 79 2000 424 429
26. K. Sonoda, S. Miyamoto, T. Hirakawa, T. Kaku, M. Nakashima, and T. Watanabe Association between RCAS1 expression and clinical outcome in uterine endometrial cancer Br. J. Cancer 89 2003 546 551
27. M. Kubokawa, M. Nakashima, T. Yao, K.I. Ito, N. Harada, and H. Nawata Aberrant intracellular localization of RCAS1 is associated with tumor progression of gastric cancer Int. J. Oncol. 19 2001 695 700
28. K. Noguchi, M. Enjoji, M. Nakamuta, M. Nakashima, H. Nishi, and I. Choi Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma Cancer Lett. 168 2001 197 202
29. H. Takahashi, H. Iizuka, M. Nakashima, T. Wada, K. Asano, and A. Ishida-Yamamoto RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin J. Dermatol. Sci. 26 2001 140 144
30. T. Suzuki, S. Inoue, W. Kawabata, J. Akahira, T. Moriya, and F. Tsuchiya EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions Br. J. Cancer 85 2001 1731 1737
31. J. Rousseau, B. Tetu, D. Caron, P. Malenfant, P. Cattaruzzi, and M. Audette RCAS1 is associated with ductal breast cancer progression Biochem. Biophys. Res. Commun. 293 2002 1544 1549
32. Y. Ito, H. Yoshida, K. Nakano, K. Kobayashi, T. Yokozawa, and K. Hirai Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma Oncology 64 2003 83 89
33. S. Hsu, L. Raine, and H. Fanger The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics Am. J. Clin. Pathol. 75 1981 816 821
34. A. Pandiella, and J. Massague Cleavage of the membrane precursor for transforming growth factor α is a regulated process Proc. Natl. Acad. Sci. U. S. A. 88 1991 1726 1730
35. K. Goishi, S. Higashiyama, M. Klagsbrun, N. Nakano, T. Umata, and M. Ishikawa Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity Mol. Biol. Cell 6 1995 967 980
36. K. Ohshima, K. Muta, M. Nakashima, S. Haraoka, T. Tutiya, and J. Suzumiya Expression of tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion Int. J. Cancer 93 2001 91 96
37. A. Engelsberg, R. Hermosilla, U. Karsten, R. Schulein, B. Dorken, and A. Rehm The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens J. Biol. Chem. 2003 22998 23007
38. K. Ikeda, M. Sato, O. Tsutsumi, F. Tsuchiya, M. Tsuneizumi, and M. Emi Promoter analysis and chromosomal mapping of human EBAG9 gene Biochem. Biophys. Res. Commun. 273 2000 654 660
39. M. Tsuneizumi, M. Emi, H. Nagai, H. Harada, G. Sakamoto, and F. Kasumi Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers Clin. Cancer Res. 7 2001 3526 3532
40. M. Tsuneizumi, H. Nagai, H. Harada, T. Kazui, and M. Emi A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer Ann. Hum. Biol. 29 2002 457 460
41. A.B. Mitra Genetic deletion and human papillomavirus infection in cervical cancer: loss of heterozygosity sites at 3p and 5p are important genetic events Int. J. Cancer 82 1999 322 324
42. J.B. Sherwood, N. Shivapurkar, W.M. Lin, R. Ashfaq, D.S. Miller, and A.F. Gazdar Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants Gynecol. Oncol. 79 2000 90 96
43. Y. Harima, K. Harima, S. Sawada, Y. Tanaka, S. Arita, and T. Ohnishi Loss of heterozygosity on chromosome 6p21.2 as a potential marker for recurrence after radiotherapy of human cervical cancer Clin. Cancer Res. 6 2000 1079 1085
44. M.M. Manolaraki, D.A. Arvanitis, G. Sourvinos, S. Sifakis, E. Koumantakis, and D.A. Spandidos Frequent loss of heterozygosity in chromosomal region 9pter-p13 in tumor biopsies and cytological material of uterine cervical cancer Cancer Lett. 176 2002 175 181
45. M.J. O'Sullivan, J.S. Rader, D.S. Gerhard, Y. Li, K.M. Trinkaus, and D.J. Gersell Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix Hum. Pathol. 32 2001 475 478
46. P.C. Huettner, D.S. Gerhard, L. Li, D.J. Gersell, K. Dunnigan, and T. Kamarasova Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features Hum. Pathol. 29 1998 364 370
47. T. Akashi, H. Oimomi, K. Nishiyama, M. Nakashima, Y. Arita, and T. Sumii Expression and diagnostic evaluation of the human-associated antigen RCAS1 in pancreatic cancer Pancreas 26 2003 49 55
48. D. Nath, N.J. Williamson, R. Jarvis, and G. Murphy Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase J. Cell Sci. 114 2001 1213 1220
49. T. Umata, M. Hirata, T. Takahashi, F. Ryu, S. Shida, and Y. Takahashi A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor J. Biol. Chem. 276 2001 30475 30482
50. K.P. Xu, D. Zoukhri, J.D. Zieske, D.A. Dartt, C. Sergheraert, and E. Loing A role for MAP kinase in regulating ectodomain shedding of APLP2 in corneal epithelial cells Am. J. Physiol. 281 2001 C603 C614
51. J.C. Montero, L. Yuste, E. Diaz-Rodrigues, A. Esparis-Ogando, and A. Pandiella Mitogen-activated protein kinase-dependent and-independent routes control sheddimg of transmembrane growth factors through multiple secretases Biochem. J. 363 2002 211 221
52. C. Page, M. Huang, X.H. Jin, K. Cho, J. Lilja, and R.K. Reynolds Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells Int. J. Oncol. 17 2000 23 28
53. B. Liu, M. Fang, Y. Lu, G.B. Millis, and Z. Fan Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells Br. J. Cancer 85 2001 303 311
54. H. Zur Hausen Human papillomaviruses in the pathogenesis of anogenital cancer Virology 184 1991 9 13
55. N. Wentzensen, R. Ridder, R. Klaes, S. Vinokurova, T. Schaefer, and M. von Knebel Doeberitz Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions Oncogene 21 2002 419 426
56. E.S. Srivatsan, R. Chakrabarti, K. Zainabadi, S.D. Pack, P. Benyamini, and M.S. Mendonca Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer Oncogene 21 2002 5631 5642
57. M. Nishimura, H. Furumoto, T. Kato, M. Kamada, and T. Aono Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer Gynecol. Oncol. 79 2000 201 206
58. T. Matsushima, M. Nakashima, K. Oshima, Y. Abe, J. Nishimura, and H. Nawata Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells Blood 2001 313 321
59. Y. Suehiro, K. Muta, M. Nakashima, Y. Abe, M. Shiratsuchi, and S. Shiokawa A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1 Eur. J. Haematol. 2005 365 373
60. K. Oshima, M. Nakashima, K. Sonoda, M. Kikuchi, and T. Watanabe Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege Clin. Exp. Immunol. 2001 481 486